Author

Riccardo Guidi

GenentechORCID 0000-0002-1033-0252Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aaron Wong· 1 shared Alexander ArlanticoiD· 1 shared Alexander R. AbbasiD· 1 shared Andréy S. ShawiD· 1 shared Cary D. AustiniD· 1 shared Christopher J. WedelesiD· 1 shared Claire L. EmsoniD· 1 shared Cynthia J. Koziol‐WhiteiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aaron Wong

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJan 13, 2026

Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis

Rojo A. Ratsimandresy, Emma Doran, Hart S. Dengler…·Mark S. Wilson

This study shows that blocking OSM and IL-6 reduces fibrosis and inflammation in pulmonary fibrosis by targeting their shared receptor and distinct pathways.

DOI 10.64898/2025.12.25.695625

mousehuman

𝕏 PostBluesky